Neurocrine Biosciences, Inc. (NBIX)

134.54 +2.15 (+1.62%) USD  |  NASDAQ  |  Jan 20, 16:00
134.42 -0.12 (-0.09%) After-Hours: 20:00
More

Neurocrine Biosciences Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Masimo Corp. Upgrade
Insulet Corp. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade